Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CHCR
Advanzeon Solutions
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
$31.66
$8.62
$58.94
$73.49M2.1532,471 shs77 shs
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
$6.00
$3.50
$7.95
N/A0.99294,806 shs773,040 shs
NextTrip, Inc. stock logo
NTRP
NextTrip
$3.51
+2.0%
$0.96
$0.68
$3.85
$26.86M1.3551,920 shs7,786 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CHCR
Advanzeon Solutions
0.00%0.00%0.00%0.00%0.00%
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
0.00%0.00%0.00%0.00%0.00%
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
0.00%0.00%0.00%0.00%0.00%
NextTrip, Inc. stock logo
NTRP
NextTrip
0.00%+12.86%+80.74%-36.53%+76.38%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CHCR
Advanzeon Solutions
N/AN/AN/AN/AN/AN/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
N/AN/AN/AN/AN/AN/AN/AN/A
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A
NextTrip, Inc. stock logo
NTRP
NextTrip
1.6324 of 5 stars
3.03.00.00.00.60.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CHCR
Advanzeon Solutions
0.00
N/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
0.00
N/AN/AN/A
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
0.00
N/AN/AN/A
NextTrip, Inc. stock logo
NTRP
NextTrip
2.00
Hold$5.0042.45% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CHCR
Advanzeon Solutions
N/AN/AN/AN/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
$383.86M0.00N/AN/A($131.19) per share0.00
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
$6.37M0.00N/AN/A$2.44 per share0.00
NextTrip, Inc. stock logo
NTRP
NextTrip
$500K53.70N/AN/A$4.16 per share0.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CHCR
Advanzeon Solutions
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
-$295.37M$49.780.67N/AN/A40.40%N/A-5.64%N/A
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
-$21.59MN/A0.00N/AN/A-324.25%45.52%8.93%N/A
NextTrip, Inc. stock logo
NTRP
NextTrip
-$10.12MN/A0.0029.25N/A-2,015.64%-580.52%-165.33%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CHCR
Advanzeon Solutions
N/AN/AN/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
N/AN/AN/AN/AN/A
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
N/AN/AN/AN/AN/A
NextTrip, Inc. stock logo
NTRP
NextTrip
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CHCR
Advanzeon Solutions
N/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
N/A
0.11
0.11
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
N/A
1.40
1.30
NextTrip, Inc. stock logo
NTRP
NextTrip
N/A
0.96
0.96

Institutional Ownership

CompanyInstitutional Ownership
CHCR
Advanzeon Solutions
N/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
62.65%
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
19.27%
NextTrip, Inc. stock logo
NTRP
NextTrip
3.81%

Insider Ownership

CompanyInsider Ownership
CHCR
Advanzeon Solutions
16.50%
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
5.46%
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
2.60%
NextTrip, Inc. stock logo
NTRP
NextTrip
9.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
CHCR
Advanzeon Solutions
2N/AN/ANot Optionable
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
3,4162.19 million2.07 millionOptionable
HTG Molecular Diagnostics, Inc. stock logo
HTGM
HTG Molecular Diagnostics
842.21 million2.16 millionOptionable
NextTrip, Inc. stock logo
NTRP
NextTrip
57.65 million6.92 millionNo Data

Recent News About These Companies

NextTrip Closes on 49% Stake in Five Star Alliance

New MarketBeat Followers Over Time

Advanzeon Solutions OTCMKTS:CHCR

Advanzeon Solutions, Inc., through its subsidiary, Pharmacy Value Management Solutions, Inc., administers and operates a sleep apnea program known as SleepMaster Solutions. The company was formerly known as Comprehensive Care Corporation and changed its name to Advanzeon Solutions, Inc. in January 2014. Advanzeon Solutions, Inc. was founded in 1969 and is headquartered in Tampa, Florida. On September 8, 2022, the voluntary petition of Advanzeon Solutions, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2020.

Capital Senior Living stock logo

Capital Senior Living NYSE:CSU

Capital Senior Living Corp. engages in the operation of senior housing communities. Its senior living options include independent living, assisted living, and memory care. The company was founded in 1990 and is headquartered in Dallas, TX.

HTG Molecular Diagnostics stock logo

HTG Molecular Diagnostics NASDAQ:HTGM

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It serves the biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

NextTrip stock logo

NextTrip NASDAQ:NTRP

Neurotrope, Inc., a biopharmaceutical company, focuses on the development of a product platform for the treatment of Alzheimer's disease. The company's lead product candidate is bryostatin, a natural product isolated from a marine invertebrate organism, a bryozoan called Bugula neritina. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, multiple sclerosis, and niemann-pick type C diseases. The company has a license agreement with The Board of Trustees of the Leland Stanford Junior University for the use of bryostatin structural derivatives, known as bryologs, for use in the treatment of central nervous system disorders, lysosomal storage diseases, stroke, cardio protection, and traumatic brain injury; and a license agreement to an accelerated synthesis of bryostatin-1. Neurotrope, Inc. also has a cooperative research and development agreement with the National Cancer Institute for the research and clinical development of Bryostatin-1. The company was founded in 2012 and is based in New York, New York.